AnorMED announced today that Dr. Mike Abrams has stepped down as president and CEO, effective immediately. He has also resigned as a director of AnorMED. Dr. Abrams has served as the company's president and CEO since founding the company in 1996.
Alex McPherson has resigned from Biomira after 15 years as president and CEO. Edward Taylor will serve as interim president and CEO.
Clinical Cell Culture has appointed Bob Atwill as its new CEO.
Donald Beeman has been named CEO of LigoCyte Pharmaceuticals in Montana.
TLV Kumar has been appointed president for Applied Biosystem's Asia Pacific operations.
Kenneth M. "Bill" Yates, DVM, has resigned as president of DelSite Biotechnologies.
Bio-nanotech company pSivida has hired Michael J. Soja as vice president, finance and CFO, and Lori H. Freedman as vice president, corporate affairs, general counsel and secretary.
Ceres has appointed Patrick McCroskey to the position of CFO.
PharmEng International announced that it has named Lawrence Tjan CFO.
Ensemble Discovery Corporation has named Nick Terrett, PhD, to the newly created role of chief scientific officer.
Pharmion Corporation has hired Dr. Andrew R. Allen to the position of chief medical officer.
MedImmune announced that Peter S. Greenleaf has joined the management team as senior vice president, marketing and sales.
Joseph S. "Jay" Mohr is joining Zelos Therapeutics as chief business officer and Martin Stogniew, Ph.D., is joining as executive vice president of development.
Geron Corp. has added Laurence Elias, M.D., to the management team as vice president, oncology clinical development.
Oscient Pharmaceuticals has promoted Hugh M. Cole to vice president, corporate development.
Catalyst Biosciences has named Marc Navre, Ph.D., as the company's vice president of drug discovery.
Xanthus Pharmaceuticals announced that John Lister-James, Ph.D. has joined the Xanthus management team as vice president, development.
Solazyme has named Dr. Anthony G. Day to the position of vice president of research and development.
ICON announced that Melton Affrime, Pharm.D., has been appointed to the position of senior vice president, global clinical pharmacology for ICON Development Solutions.
Generex has hired George Markus as its manager of regulatory affairs. In addition, Antigen Express, the company's wholly owned immunotherapeutics subsidiary, has hired Margaret Sposato as a senior research associate.
Amazon Biotech has added Evan Bental as a regulatory assistant.
MethylGene has elected Jay Moorin, partner at ProQuest Investments III, L.P., to MethylGene's board of directors.
Affymax has elected John P. Walker to the company's board of directors.
Cephalon has elected Kevin E. Moley to its board of directors.
Forest Laboratories has named Nesli Basgoz, M.D., to its board.
NitroMed has appointed Christopher J. Sobecki to its board of directors.
Pluristem Life Systems has named Edwin M Horwitz, M.D., PhD., to its scientific advisory board.